Opiate antagonists in the treatment of stroke.
- 1 May 1984
- journal article
- abstracts
- Published by Wolters Kluwer Health in Stroke
- Vol. 15 (3), 575-578
- https://doi.org/10.1161/01.str.15.3.575
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Effect of naloxone on neurologic deficit and cortical blood flow during focal cerebral ischemia in catsLife Sciences, 1982
- Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effectsLife Sciences, 1982
- Failure of MIF-1 or naloxone to reverse ischemic-induced neurologic deficits in gerbilsPharmacology Biochemistry and Behavior, 1982
- Relative involvement of receptors subtypes in opioid-induced inhibition of intestinal motility in miceLife Sciences, 1982
- In vivo evaluation of the opiate delta receptor antagonist ICI 154, 129Life Sciences, 1982
- Naloxone or TRH fails to improve neurologic deficits in gerbil models of “stroke”Life Sciences, 1982
- Multiple opiate receptors: Emerging conceptsLife Sciences, 1981
- NALOXONE REVERSAL OF ISCHAEMIC NEUROLOGICAL DEFICITS IN MANThe Lancet, 1981
- On the specificity of naloxone as an opiate antagonistLife Sciences, 1979
- Identification of two related pentapeptides from the brain with potent opiate agonist activityNature, 1975